Florida Cancer Specialists & Research Institute Announces Leadership Appointments in Pharmacy Services

7/29, 6:18 PM (Source: GlobeNewswire)

Fort Myers, Fla, July 29, 2021 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute (FCS) has promoted two leaders within its Pharmacy Services department. Ray Bailey, BPharm, RPH has been promoted to Senior Vice President of Pharmacy Services and John Mills has been promoted to Vice President of Pharmacy Services.

Bailey will maintain and expand pharmaceutical and trade partnerships to support the statewide practice’s long-term growth initiatives for pharmacy services, including pharmacy operations and Rx to Go, its oral oncolytic specialty pharmacy. Bailey holds undergraduate and graduate degrees from the University of Georgia. An active member of several professional associations, he serves as an advisory board member for the Community Oncology Pharmacy Alliance (COPA) and the National Community Oncology Dispensing Association.

With daily oversight of all pharmacy services for Rx to Go, Mills actively supports pharmacy operations and future expansion activities. He joined FCS in 2019 as Director of Payer Relations and Business Strategy and was promoted to Senior Director of Pharmacy the following year.

FCS Chief Procurement Officer Paul Chadwick said, “Ray is a highly respected leader throughout the industry. Since joining FCS in 2009, he has been instrumental in developing our pharmacy area and ensuring our patients receive the medications and support they need.”  He added,

“John has been influential in strengthening our payer relationships, which has enabled our in-house pharmacy to serve more patients, eliminating delays in treatment.” 

###

About Florida Cancer Specialists & Research Institute
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. Over the past 5 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, MD Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.

Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies, and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians, and staff.

*Prior to approval

Attachment


Michelle Robey
Florida Cancer Specialists & Research Institute 
813.767.9398
Michelle.Robey@FLCancer.com
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.